amitriptyline has been researched along with Autoimmune Demyelinating Disease, Peripheral in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leys, D | 2 |
| Petit, H | 2 |
| Pasquier, F | 1 |
| Lamblin, MD | 1 |
| Dubois, F | 1 |
2 other studies available for amitriptyline and Autoimmune Demyelinating Disease, Peripheral
| Article | Year |
|---|---|
Clinical signs of amyotrophic lateral sclerosis developing after polyradiculoneuropathy associated with amitriptyline.
Topics: Amitriptyline; Amyotrophic Lateral Sclerosis; Drug Overdose; Humans; Polyradiculoneuropathy; Reflex, | 1990 |
Acute polyradiculoneuropathy after amitriptyline overdose.
Topics: Amitriptyline; Female; Humans; Middle Aged; Polyradiculoneuropathy; Suicide, Attempted | 1987 |